Evidence map›Paper›PMID 38094623›Full record

ArticleFrontiers in microbiology2023

Characterizations of novel broad-spectrum lytic bacteriophages

S K Tousif Ahamed, Srijana Rai, Chiranjib Guin, Rameez Moidu Jameela, Somasri Dam, Dhiviya Prabaa Muthuirulandi Sethuvel, V Balaji, Nabanita Giri

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. New microbes and new infections · 2026
    Review
  2. Integrated Morphological, Functional, and Genomic Analysis of a Novel Lytic Phage (VIT_AJPSC) Infecting Multidrug-Resistant Shigella dysenteriae.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026
    Article
  3. Article
  4. Isolation and characterization of lyticFrontiers in cellular and infection microbiology · 2026
    Article
  5. Article
  6. Article
  7. Comprehensive Approaches to CombattingAntibiotics (Basel, Switzerland) · 2024
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

S K Tousif AhamedDepartment of Microbiology, Acharya Prafulla Chandra College, New Barrackpore, Kolkata, India.
Srijana RaiDepartment of Microbiology, Acharya Prafulla Chandra College, New Barrackpore, Kolkata, India.
Chiranjib GuinDepartment of Microbiology, Acharya Prafulla Chandra College, New Barrackpore, Kolkata, India.
Rameez Moidu JameelaDepartment of Microbiology, Bose Institute, Kolkata, West Bengal, India.
Somasri DamDepartment of Microbiology, The University of Burdwan, Bardhaman, West Bengal, India.
Dhiviya Prabaa Muthuirulandi SethuvelDepartment of Research and Development, Bioberrys Healthcare and Research Centre, Vellore, Tamil Nadu, India.
V BalajiDepartment of Clinical Microbiology, Christian Medical College, Vellore, Tamil Nadu, India.
Nabanita GiriDepartment of Microbiology, Acharya Prafulla Chandra College, New Barrackpore, Kolkata, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The evidence and prevalence of multidrug-resistant (MDR)

Indexed as

bacteriophagegenome sequencinglarge terminasephage therapyShigella spp.

Identifiers

PMID38094623
PMCPMC10716491

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.